Ircon International Ltd Q1 FY27 Results Analysis: PAT Plunges 43.6%, Finance Costs Surge
Ircon International Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 1,955.83 Cr (+9.49% YoY) and PAT growth of -43.64% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | August 12, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 1,955.83 Cr (+9.49% YoY) |
| PAT (Q1) | Rs. 92.74 Cr (-43.64% YoY) |
| EBITDA margin | 13.64% (-350 bps YoY) |
| EPS (Q1) | Rs. 0.99 (-43.43% YoY) |
| Market cap | Rs. 11,871.13 Cr |
| CMP | Rs. 126.18 |
Quarter Snapshot
IRCON's standalone business is healthy with revenue growth and margin beating guidance, but consolidated results are severely impacted by subsidiary debt costs and JV losses, causing a 43.6% PAT decline. The core EPC operations are on track to meet revenue guidance, but the PAT margin miss and rising finance costs are key concerns that need resolution from the subsidiary portfolio.
Key Investment Insights
Key Positives
- Consolidated revenue grew 9.5% YoY to Rs.1,955.83 Cr, with international revenue up 46%.
- Standalone PAT grew 8.6% YoY to Rs.163.52 Cr, reflecting healthy core operations.
- Standalone core EBITDA margin of 5.31% exceeded the FY27 guidance range of 4.0-4.5%.
- Consolidated core EBITDA margin of 9.81% exceeded the ~9% guidance target.
- International segment revenue grew 28% YoY (standalone), maintaining high margins.
Risk Factors
- Consolidated PAT (owners) fell 43.6% YoY to Rs.92.74 Cr, entirely due to subsidiary and JV losses.
- Finance costs surged 42.2% YoY to Rs.106.98 Cr, driven by PPP SPV debt servicing.
- CERL JV losses swung from +Rs.17.90 Cr to -Rs.13.36 Cr, a Rs.31.26 Cr YoY negative swing.
- Consolidated PAT margin of 4.74% missed the FY27 guidance of 6.1-6.3%.
- Domestic segment margin eroded: consolidated domestic PBT before interest fell 20.2% YoY despite revenue growth.
- Board composition non-compliance fines from stock exchanges indicate governance concerns.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.